GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (FRA:Q9T) » Definitions » Net Debt Paydown Yield %

ME Therapeutics Holding (FRA:Q9T) Net Debt Paydown Yield % : -0.02% (As of Apr. 14, 2025)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Net Debt Paydown Yield %?

Net Debt Paydown Yield % is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. It is a measure of a company's willingness and ability to reduce its debt. As of today, ME Therapeutics Holding's Net Debt Paydown Yield % was -0.02%.


ME Therapeutics Holding Net Debt Paydown Yield % Historical Data

The historical data trend for ME Therapeutics Holding's Net Debt Paydown Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Net Debt Paydown Yield % Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23 Aug24
Net Debt Paydown Yield %
- - 0.01

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
Net Debt Paydown Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.05 0.01 -0.07 -

Competitive Comparison of ME Therapeutics Holding's Net Debt Paydown Yield %

For the Biotechnology subindustry, ME Therapeutics Holding's Net Debt Paydown Yield %, along with its competitors' market caps and Net Debt Paydown Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ME Therapeutics Holding's Net Debt Paydown Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ME Therapeutics Holding's Net Debt Paydown Yield % distribution charts can be found below:

* The bar in red indicates where ME Therapeutics Holding's Net Debt Paydown Yield % falls into.


;
;

ME Therapeutics Holding Net Debt Paydown Yield % Calculation

ME Therapeutics Holding's Net Debt Paydown Yield % for the quarter that ended in Feb. 2025 is calculated as:

Net Debt Paydown Yield %
=( TTM Average Debt   (1-Year Ago))-TTM Average Debt )/Market Cap
=( 0.03-0.07 )/120.21632
=-0.04 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Net Debt Paydown Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.


ME Therapeutics Holding  (FRA:Q9T) Net Debt Paydown Yield % Explanation

Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced. In other words, it is a measure of the willingness and ability of a firm's management to pay down debt. Companies that have high debt paydown yields indicate that they are more aggressive with paying down debt.

In the calculation of Net Debt Paydown Yield %, we use the reductions of TTM average total debt one-year-ago and TTM average total debt at present, divided by its Market Cap.

We calculating the TTM average debt by adding up the total debt, calculated by the sum of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation, in the trailing twelve months(TTM) divided by the counts of the total debt, accoring to the company's report frequency.


ME Therapeutics Holding Net Debt Paydown Yield % Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Net Debt Paydown Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


ME Therapeutics Holding Business Description

Traded in Other Exchanges
Address
177 Robson St., Vancouver, BC, CAN, V6B 0N3
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding Headlines

No Headlines